Archive · 13 Nov 2025
Teijin and BioVaram Forge Strategic Alliance for Regenerative Medicine in Japan and India
Two companies, Teijin from Japan and BioVaram from India, are joining forces.
Teijin makes special medical devices and treatments that help bodies heal themselves, like patches for the heart and medicine made from cells.
BioVaram is good at creating new kinds of medical materials and diagnostic tools.
Together, they want to bring Teijin's healing products to people in India.
They also want to bring BioVaram's new inventions to people in Japan.
They believe that by working together, they can create even better medical solutions for both countries and help more people get well.
Teijin and BioVaram have formed a strategic alliance to expand regenerative medicine and implantable medical device markets.
Teijin's SYNFOLIUM® cardiovascular patch and regenerative medicine products are planned for introduction in India.
BioVaram's technologies, including exosome-based products and bio-derived materials, will be explored for the Japanese market.
The alliance aims to leverage each company's strengths to address unmet medical needs in Japan and India.
Both companies will collaborate on assessing feasibility, regulatory pathways, and market needs for their respective product introductions.
- Who
- Teijin Limited and BioVaram (UR Advanced Therapeutics Pvt Ltd.)
- What
- Signed a business alliance agreement to expand regenerative medicine and implantable medical device usage in India and Japan.
- When
- Announced today
- Where
- Japan and India
- Why
- To address unmet medical needs by leveraging each company's strengths and technologies in advanced healthcare markets.
- Companies Involved
- Teijin Limited (Japan), BioVaram (UR Advanced Therapeutics Pvt Ltd., India)
- Objective
- Expand usage of Teijin's regenerative medicine and implantable devices in India; introduce BioVaram's products in Japan.
- Key Teijin Products for India
- SYNFOLIUM® (cardiovascular repair patch), regenerative medicine products from Japan Tissue Engineering (J-TEC).
- Key BioVaram Products for Japan
- Exosome-based diagnostics and therapeutics, Extracellular Matrix mimics, Type I atelocollagen.
- Announced
- Today
- BioVaram Recognition
- Named 'Top 5 Startup' at BioAsia 2024